Back to top

earnings: Archive

Zacks Equity Research

Why Teradyne (TER) International Revenue Trends Deserve Your Attention

Examine the evolution of Teradyne's (TER) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

TERPositive Net Change

Zacks Equity Research

Why KLA (KLAC) International Revenue Trends Deserve Your Attention

Review KLA's (KLAC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

KLACPositive Net Change

Zacks Equity Research

International Markets and Capri Holdings (CPRI): A Deep Dive for Investors

Review Capri Holdings' (CPRI) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

CPRINegative Net Change

Zacks Equity Research

Stay Ahead of the Game With Tapestry (TPR) Q4 Earnings: Wall Street's Insights on Key Metrics

Beyond analysts' top-and-bottom-line estimates for Tapestry (TPR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

TPRPositive Net Change

Zacks Equity Research

Unlocking Q2 Potential of Nice (NICE): Exploring Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Nice (NICE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

NICEPositive Net Change

Zacks Equity Research

Unveiling Amcor (AMCR) Q4 Outlook: Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Amcor (AMCR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

AMCRPositive Net Change

Zacks Equity Research

Insights Into Applied Materials (AMAT) Q3: Wall Street Projections for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Applied Materials (AMAT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.

AMATPositive Net Change

Zacks Equity Research

Curious about Deere (DE) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Deere (DE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.

DENegative Net Change

Zacks Equity Research

International Flavors (IFF) Reliance on International Sales: What Investors Need to Know

Examine the evolution of International Flavors' (IFF) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

IFFNegative Net Change

Zacks Equity Research

Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock

Explore Insmed's (INSM) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

INSMPositive Net Change

Zacks Equity Research

Unlocking Q2 Potential of Advance Auto Parts (AAP): Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of Advance Auto Parts (AAP) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

AAPNegative Net Change

Zacks Equity Research

APA Q2 Earnings Shine With Beat on Both Top and Bottom Lines

APA tops Q2 forecasts with stronger production, cost cuts. and shareholder returns despite softer oil prices.

COPNegative Net Change APAPositive Net Change EQTPositive Net Change EOGPositive Net Change

Ekta Bagri

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.

GILDNegative Net Change INONegative Net Change DERMNegative Net Change ZVRAPositive Net Change

Zacks Equity Research

Embraer's Q2 Earnings Miss Estimates, Revenues Increase Y/Y

Embraer posts wider-than-expected Q2 loss despite 21.8% revenue jump, with gains across all business segments and a record $29.7B backlog.

BAPositive Net Change ERJPositive Net Change LDOSNegative Net Change RTXPositive Net Change

Zacks Equity Research

Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract

BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.

BSXNegative Net Change BRKRNegative Net Change MEDPNegative Net Change WGSNegative Net Change

Zacks Equity Research

PowerFleet (AIOT) Q1 Earnings Match Estimates

PowerFleet (AIOT) delivered earnings and revenue surprises of 0.00% and +0.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AIOTNegative Net Change REVGNegative Net Change

Zacks Equity Research

Perion Network (PERI) Q2 Earnings and Revenues Surpass Estimates

Perion Network (PERI) delivered earnings and revenue surprises of +52.94% and +1.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

PERIPositive Net Change SMWBPositive Net Change

Zacks Equity Research

Permian Resources Q2 Earnings Decline Y/Y on Increased Expenses

PR posts a second-quarter earnings decline on higher costs and weaker prices but raises 2025 production outlook.

IMOPositive Net Change TRPPositive Net Change CTRANegative Net Change PRPositive Net Change

Zacks Equity Research

International Money Express (IMXI) Tops Q2 Earnings Estimates

International Money Express (IMXI) delivered earnings and revenue surprises of +4.08% and -1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

IMXIPositive Net Change PAGSPositive Net Change

Zacks Equity Research

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +21.74% and -71.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ROIVPositive Net Change FENCNo Net Change

Zacks Equity Research

Aaon (AAON) Q2 Earnings and Revenues Miss Estimates

Aaon (AAON) delivered earnings and revenue surprises of -29.03% and -6.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AAONPositive Net Change MPTIPositive Net Change

Zacks Equity Research

Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of -60.00% and -73.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

HUMAPositive Net Change EDITNo Net Change

Zacks Equity Research

Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates

Kymera Therapeutics (KYMR) delivered earnings and revenue surprises of -14.46% and -66.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

KYMRNegative Net Change CDXSPositive Net Change

Zacks Equity Research

Monday.com (MNDY) Q2 Earnings and Revenues Beat Estimates

Monday.com (MNDY) delivered earnings and revenue surprises of +29.76% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

MNDYPositive Net Change GTLBPositive Net Change

Zacks Equity Research

Green Plains Renewable Energy (GPRE) Reports Q2 Loss, Misses Revenue Estimates

Green Plains (GPRE) delivered earnings and revenue surprises of -46.43% and -6.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

GPREPositive Net Change FSIPositive Net Change